Literature DB >> 34972650

Nutritional status and lung function in children with pancreatic-sufficient cystic fibrosis.

Ankitha Madde1, William Okoniewski1, Don B Sanders2, Clement L Ren2, Daniel J Weiner1, Erick Forno3.   

Abstract

BACKGROUND: There is a strong association between nutrition and long-term FEV1 in cystic fibrosis (CF), but studies have been driven by data from subjects with pancreatic insufficiency (PI-CF). We thus evaluated the association between body mass index (BMI) and FEV1 percent-predicted (FEV1pp) in children with pancreatic sufficiency (PS-CF) and contrasted it with the association in PI-CF.
METHODS: We utilized data from the CF Foundation Patient Registry. The cohort included children born 1995-2010, diagnosed <2 years of age, and who had annualized data on BMI percentile and FEV1pp at ages 6-16 years. Pancreatic status was defined based on pancreatic enzyme replacement therapy. The association between BMI and FEV1 was evaluated using linear and mixed-effects longitudinal regression.
RESULTS: There were 424 children with PS-CF and 7,849 with PI-CF. The association between BMI and FEV1 differed significantly by pancreatic status: each 10-pct higher BMI was associated with 2% [95%CI = 1.9-2.1] higher FEV1pp in PI-CF, compared to just 0.9% [0.5-1.3] in PS-CF (PINTERACTION < 0.001). Within the at-risk nutritional category (BMI <25pct), each 10-pct higher BMI was associated with 5% higher FEV1pp in PI-CF, but no significant increase in PS-CF. Moreover, in PS-CF, overweight/obesity (BMI ≥85pct) was associated with decreasing FEV1pp. In addition, FEV1pp decline through age 20 years in youth with PS-CF was modest (-0.6% per year) and independent of BMI (BMI*age PINTERACTION = 0.37).
CONCLUSIONS: In children with PS-CF, BMI remains an important determinant of lung function. However, it may be less critical to attain a BMI >50th percentile; and BMI ≥85th percentile may be detrimental.
Copyright © 2021 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BMI; Cytic fibrosis; FEV1; Lung function; Nutrition; Pancreatic insufficiency

Year:  2021        PMID: 34972650      PMCID: PMC9237179          DOI: 10.1016/j.jcf.2021.12.014

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.527


  26 in total

1.  Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

Authors:  Michael W Konstan; Wayne J Morgan; Steven M Butler; David J Pasta; Marcia L Craib; Stefanie J Silva; Dennis C Stokes; Mary Ellen B Wohl; Jeffrey S Wagener; Warren E Regelmann; Charles A Johnson
Journal:  J Pediatr       Date:  2007-06-22       Impact factor: 4.406

2.  Overweight and obesity in patients with cystic fibrosis: a center-based analysis.

Authors:  Reem M Hanna; Daniel J Weiner
Journal:  Pediatr Pulmonol       Date:  2014-04-23

Review 3.  Cystic Fibrosis Lung Disease: An Overview.

Authors:  Nelson L Turcios
Journal:  Respir Care       Date:  2019-11-26       Impact factor: 2.258

4.  Overweight and obesity in deltaF508 homozygous cystic fibrosis.

Authors:  Dagmar Kastner-Cole; Colin N A Palmer; Simon A Ogston; Anil Mehta; Somnath Mukhopadhyay
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

5.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

6.  Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study.

Authors:  Anne L Stephenson; Lisa A Mannik; Shirley Walsh; Michelle Brotherwood; Ronalee Robert; Pauline B Darling; Rosane Nisenbaum; Joost Moerman; Sanja Stanojevic
Journal:  Am J Clin Nutr       Date:  2013-02-06       Impact factor: 7.045

7.  Early attained weight and length predict growth faltering better than velocity measures in infants with CF.

Authors:  Sonya L Heltshe; Drucy S Borowitz; Daniel H Leung; Bonnie Ramsey; Nicole Mayer-Hamblett
Journal:  J Cyst Fibros       Date:  2014-06-07       Impact factor: 5.482

8.  Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study.

Authors:  David Taylor-Robinson; Margaret Whitehead; Finn Diderichsen; Hanne Vebert Olesen; Tania Pressler; Rosalind L Smyth; Peter Diggle
Journal:  Thorax       Date:  2012-05-03       Impact factor: 9.139

Review 9.  Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review.

Authors:  Virginia A Stallings; Lori J Stark; Karen A Robinson; Andrew P Feranchak; Hebe Quinton
Journal:  J Am Diet Assoc       Date:  2008-05

Review 10.  The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis.

Authors:  Valentine Sergeev; Frank Y Chou; Grace Y Lam; Christopher Michael Hamilton; Pearce G Wilcox; Bradley S Quon
Journal:  Ann Am Thorac Soc       Date:  2020-02
View more
  1 in total

Review 1.  The Changing Landscape of Nutrition in Cystic Fibrosis: The Emergence of Overweight and Obesity.

Authors:  Julianna Bailey; Stefanie Krick; Kevin R Fontaine
Journal:  Nutrients       Date:  2022-03-13       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.